1. Home
  2. Search

Search

Search results

50 results found

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

Publication: Journal Article
Stephenson, Kathryn E., Chen Sabrina Tan, Stephen R. Walsh-, -Kayvon Modjarrad, and Dan H. Barouch. 2020. “Safety and Immunogenicity of a Zika Purified Inactivated Virus Vaccine Given via Standard, Accelerated, or Shortened Schedules: A Single-Centre, Double-Blind, Sequential-Group, Randomised, Placebo-Controlled, Phase 1 Trial”. Lancet Infectious Diseases 20 (9): 1061-70.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission during the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study using Genomic Epidemiology

Publication: Journal Article
Banga, Jaspreet, Taylor Brock-Fisher, Brittany A. Petros-, -Pardis C. Sabeti, and Kathryn E. Stephenson. 2024. “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission During the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study Using Genomic Epidemiology”. MedRxiv.

Kathryn Stephenson, MD, MPH

Person: Principal Investigator, HVTN CRS Leader
Dr. Stephenson is a physician-scientist in the Center for Virology and Vaccine Research (CVVR) and the Division of Infectious Diseases at Beth Israel Deaconess Medical Center (BIDMC) in Boston, Massachusetts. She is also an Associate Professor of Medicine at Harvard Medical School. She has expertise...